David M. Knott Jr’s Axsome Therapeutics AXSM Stock Holding History

David M. Knott Jr’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,000	Closed	-$626K	–	90
2025 Q2	$626K	Buy	+6,000	New	+$635K	0.28%	43

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

David M. Knott Jr's AXSM Position: Q3 2025 in Review

David M. Knott Jr sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 6,000 shares — an estimated $626K sold.

David M. Knott Jr first reported a position in AXSM in Q2 2025 and held it in 1 quarter. The position peaked at $626K in Q2 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

David M. Knott Jr reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
David M. Knott Jr sold 6,000 Axsome Therapeutics shares in Q3 2025, an estimated $626K.
David M. Knott Jr first reported a position in Axsome Therapeutics in Q2 2025 and held it in 1 quarter.
David M. Knott Jr's Axsome Therapeutics position peaked at $626K in Q2 2025.
355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on David M. Knott Jr's 13F filing for Q3 2025, filed 12 Nov 2025.